Xuantai Medical (688247.SH): Injectable Echinocandins and other candidates to be selected for national centralized pharmaceutical procurement

According to the news from Zhito Finance APP, Xuantai Pharmaceutical (688247.SH) announced that it recently participated in the bidding organized by the National Organization for Drug Procurement Office for the twelfth batch of national centralized drug procurement. According to the "Proposed Winning Results Announcement for the 12th Batch of National Organized Drug Centralized Procurement" issued by the Joint Procurement Office on July 31, 2026, on the Shanghai Sunshine Medical Procurement Network, the company's product, injectable isavuconazole, and the co-developed product enzalutamide tablets are proposed to be selected in this centralized procurement.